News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals
Thursday, September 29, 2022An affiliate of investment firm SK Capital Partners LP announced today that it has entered into an agreement to acquire Apotex Pharmaceutical Holdings Inc a global pharmaceutical company based in Canada Apotex is recognized for its commitment to prod...
Odyssey Health, Inc. Announces Successful Completion of Phase I Clinical Trial for Concussion Drug
Thursday, September 29, 2022Odyssey Health Inc formerly known as Odyssey Group International Inc a company dedicated to developing innovative medical products that improve lives is pleased to announce
Ayala Pharmaceuticals Announces Fast Track Designation Granted by US FDA for AL102 in Progressing Desmoid Tumors
Wednesday, September 28, 2022Ayala Pharmaceuticals Inc a clinicalstage oncology company focused on developing and commercializing small molecule therapeutics for rare tumors and aggressive cancers has announced that the US Food and Drug Administration
Pharming Announces US FDA Acceptance for Priority Review of its New Drug Application for Leniolisib
Wednesday, September 28, 2022Pharming Group NV has announced that the US Food and Drug Administration FDA has accepted its New Drug Application NDA for leniolisib a selective phosphoinositide kinase delta PIK inhibitor for priority review Leniolisib is intended to treat primary...
SeraNovo and Ildong Pharmaceutical to Collaborate on Research Projects
Tuesday, September 27, 2022SeraNovo BV is excited to announce the successful completion of a multicompound agreement with Ildong Pharmaceutical a renowned pharmaceutical company based in Seoul South Korea Ildong Pharmaceutical focuses on the research and development of small m...
Innocoll and DURECT Announce U.S. launch of POSIMIR®
Tuesday, September 27, 2022Innocoll Pharmaceuticals Limited a biotechnology company and a portfolio business of Gurnet Point Capital along with DURECT Corporation Nasdaq DRRX has announced the recent commercial launch of POSIMIR bupivacaine solution in the United States POSIMI...
Coave Therapeutics to Present at Cell and Gene Meeting on the Mesa
Monday, September 26, 2022Coave Therapeutics gene therapies CNS diseases eye diseases company overview Cell and Gene Meeting on the Mesa Carlsbad California
Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies
Thursday, September 22, 2022The FDA has accepted ImmunityBio Incs Biologics License Application BLA for review The BLA focuses on their antibody cytokine fusion protein as a potential treatment for BCGunresponsive nonmuscleinvasive bladder cancer carcinoma in situ CIS ImmunityB...
CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development
Wednesday, September 21, 2022CytoReason today announced an extension of its multiyear partnership with Pfizer to use CytoReasons artificial intelligence technology for Pfizers drug development programs Under the terms of the agreement Pfizer will make a M equity investment have...
Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19
Wednesday, September 21, 2022AstraZenecas Evusheld tixagevimab and cilgavimab formerly AZD a longacting antibody combination has been approved in the European Union EU for the treatment of adults and adolescents aged years and older weighing at least kg with COVID who do not r...
